New test aims to spot kidney damage risk before it happens
NCT ID NCT04864847
Summary
This study is testing a new, quick urine test that measures a protein called L-FABP. The goal is to see if this test can predict which patients are at high risk for kidney damage within two days after receiving contrast dye during heart or blood vessel procedures. Researchers will enroll 450 adults with reduced kidney function or other risk factors to validate the test's accuracy. If successful, this could help doctors take early steps to protect patients' kidneys.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chandler Regional Medical Center
Chandler, Arizona, 85224, United States
-
Clearwater Cardiovascular Consultants
Clearwater, Florida, 33756, United States
-
John Muir Health
Concord, California, 94520, United States
-
Sinai Hospital of Baltimore
Baltimore, Maryland, 21215, United States
-
University of Florida at Jacksonville
Jacksonville, Florida, 32209, United States
-
University of Oklahoma
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.